People with mild asthma may not need daily medicine to prevent flare-ups, as doctors now recommend. A study found that patients who take medicine only when asthma attacks occur fare about as well as ...

Asthma is a global issue. It’s estimated that more than 334 million people around the world have asthma. It’s a chronic disease that makes it hard to breathe. Asthma often starts in childhood, but it ...

Add Yahoo as a preferred source to see more of our stories on Google. what-is-asthma-jpg The wheezing. The coughing. The extreme and sudden shortness of breath. These are symptoms that are attached to ...

Primatene Mist is the only OTC inhaler approved by the FDA for mild asthma in people 12 and older. Primatene Mist uses epinephrine, while albuterol uses albuterol sulfate, and they have different side ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...

ARLINGTON HEIGHTS, Ill. (April 15 , 2025) - Did you know about 24 million people in the United States have asthma, representing roughly 8% of the population? May is Asthma and Allergy Awareness Month, ...

Just about everyone with asthma knows the drill. Take a daily snort of a prescription inhaler filled with a steroid that helps fight inflammation, to prevent trouble. Not everyone actually does this, ...

Please provide your email address to receive an email when new articles are posted on . BATURA showed a 47% reduction in severe exacerbation risk with albuterol budesonide vs. albuterol in patients ...

Inhaled corticosteroids (ICSs) are recommended as a first-line treatment for asthma, but many clinicians are challenged to determine whether patients with mild, well-controlled asthma should continue ...

The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...